145 related articles for article (PubMed ID: 10985665)
1. Upregulation of interleukin-12 receptor on peripheral blood mononuclear cells and HLA class I, HLA class II or ICAM-1 on melanoma cells by B7.1 and interleukin-12: a mechanism for immunostimulatory impact of melanoma cells adenovirally transfected with B7.1 and IL12?
Yue FY; Cao L; Hemmi S; Geertsen R; Laine E; Burg G; Dummer R
Melanoma Res; 2000 Aug; 10(4):313-22. PubMed ID: 10985665
[TBL] [Abstract][Full Text] [Related]
2. IL-12 directly up-regulates the expression of HLA class I, HLA class II and ICAM-1 on human melanoma cells: a mechanism for its antitumor activity?
Yue FY; Geertsen R; Hemmi S; Burg G; Pavlovic J; Laine E; Dummer R
Eur J Immunol; 1999 Jun; 29(6):1762-73. PubMed ID: 10382738
[TBL] [Abstract][Full Text] [Related]
3. Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppression by interleukin 10.
Dummer R; Yue FY; Pavlovic J; Geertsen R; Döhring C; Moelling K; Burg G
Br J Cancer; 1998 May; 77(9):1413-9. PubMed ID: 9652756
[TBL] [Abstract][Full Text] [Related]
4. Human melanoma cells transfected with the B7-2 co-stimulatory molecule induce tumor-specific CD8+ cytotoxic T lymphocytes in vitro.
Imro MA; Dellabona P; Manici S; Heltai S; Consogno G; Bellone M; Rugarli C; Protti MP
Hum Gene Ther; 1998 Jun; 9(9):1335-44. PubMed ID: 9650618
[TBL] [Abstract][Full Text] [Related]
5. Human autologous in vitro models of glioma immunogene therapy using B7-2, GM-CSF, and IL12.
Parney IF; Farr-Jones MA; Kane K; Chang LJ; Petruk KC
Can J Neurol Sci; 2002 Aug; 29(3):267-75. PubMed ID: 12195617
[TBL] [Abstract][Full Text] [Related]
6. The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures.
Hemmi S; Geertsen R; Mezzacasa A; Peter I; Dummer R
Hum Gene Ther; 1998 Nov; 9(16):2363-73. PubMed ID: 9829535
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients.
Ugurel S; Uhlig D; Pföhler C; Tilgen W; Schadendorf D; Reinhold U
Cancer Immunol Immunother; 2004 Jun; 53(6):551-9. PubMed ID: 14727087
[TBL] [Abstract][Full Text] [Related]
8. Alpha-melanocyte stimulating hormone can reduce T-cell interaction with melanoma cells in vitro.
Hedley SJ; Murray A; Sisley K; Ghanem G; Morandini R; Gawkrodger DJ; Mac Neil S
Melanoma Res; 2000 Aug; 10(4):323-30. PubMed ID: 10985666
[TBL] [Abstract][Full Text] [Related]
9. CD80-mediated induction of immunostimulation in two ocular melanoma cell lines is augmented by interferon-gamma.
Mulcahy KA; Alexander S; Platts KE; Wardle C; Sisley K; Rennie IG; Murray AK
Melanoma Res; 2002 Apr; 12(2):129-38. PubMed ID: 11930109
[TBL] [Abstract][Full Text] [Related]
10. Restoration of alloreactivity of melanoma by transduction with B7.1.
Brady MS; Lee F; Eckels DD; Ree SY; Latouche JB; Lee JS
J Immunother; 2000; 23(3):353-61. PubMed ID: 10838664
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cells to be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytes.
Mazzocchi A; Melani C; Rivoltini L; Castelli C; Del Vecchio M; Lombardo C; Colombo MP; Parmiani G
Cancer Immunol Immunother; 2001 Jun; 50(4):199-211. PubMed ID: 11459172
[TBL] [Abstract][Full Text] [Related]
12. Adenoviral transduction of melanoma cells with B7-1: antitumor immunity and immunosuppressive factors.
Boxhorn HK; Smith JG; Chang YJ; Guerry D; Lee WM; Rodeck U; Turka LA; Eck SL
Cancer Immunol Immunother; 1998 Jul; 46(5):283-92. PubMed ID: 9690457
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma-induced ICAM-1 and CD40 expression, complete lack of HLA-DR and CD80 (B7.1), and inconsistent HLA-ABC expression in basal cell carcinoma: a possible role for interleukin-10?
Kooy AJ; Prens EP; Van Heukelum A; Vuzevski VD; Van Joost T; Tank B
J Pathol; 1999 Feb; 187(3):351-7. PubMed ID: 10398091
[TBL] [Abstract][Full Text] [Related]
14. Effect of B7.1-transfected human colon cancer cells on the induction of autologous tumour-specific cytotoxic T cells.
Miyazono Y; Kamogawa Y; Ryo K; Furukawa T; Mitsuhashi M; Yamauchi K; Kameoka T; Hayashi N
J Gastroenterol Hepatol; 1999 Oct; 14(10):997-1003. PubMed ID: 10530496
[TBL] [Abstract][Full Text] [Related]
15. Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cells.
Yang S; Darrow TL; Seigler HF
Cancer Res; 1997 Apr; 57(8):1561-8. PubMed ID: 9108460
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of melanoma-associated antigens and molecules involved in antigen processing and presentation in three cell lines established from a single patient.
Kovalcsik E; John J; Turner M; Birchall L; Sage D; Whittle R; Dalgleish A; Pandha H
Melanoma Res; 2004 Dec; 14(6):463-71. PubMed ID: 15577316
[TBL] [Abstract][Full Text] [Related]
17. T cell activation by antigens on human melanoma cells--co-stimulation by B7-1 is neither sufficient nor necessary to stimulate IL-2 secretion by melanoma-specific T cell clones in vitro.
Viret C; Gervois N; Guilloux Y; Le Dréan E; Diez E; Jotereau F
Int Immunol; 1995 Oct; 7(10):1535-43. PubMed ID: 8562498
[TBL] [Abstract][Full Text] [Related]
18. Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12.
Okada N; Iiyama S; Okada Y; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T; Fujita T; Yamamoto A
Cancer Gene Ther; 2005 Jan; 12(1):72-83. PubMed ID: 15389286
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte-melanoma interaction: role of surface molecules.
Becker JC; Bröcker EB
Recent Results Cancer Res; 1995; 139():205-14. PubMed ID: 7597291
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO
Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]